Washington D.C. – Today, the US District Court for the Western District of Texas threw out a lawsuit against the Biden administration brought by the Pharmaceutical Research and Manufacturers of America and allies seeking to block Medicare from negotiating lower drug prices with manufacturers under the Inflation Reduction Act because the plaintiffs “did not have subject matter jurisdiction to bring the lawsuit.” Accountable.US Executive Director Tony Carrk issued the following statement in response:
Big PhRMA is so desperate to stop the Biden administration from lowering drug costs for seniors that they’re clogging the judicial system with spam lawsuits even in courtrooms they have no jurisdiction in. The big drug industry will say or do anything to strip away Medicare’s new negotiation powers so that they can go back to business-as-usual price-gouging seniors on life-saving medicines.”
Read More on Gross Pharma Profiteering From Accountable.US:
- Drug Company Giant Suing to End Biden Cost-Lowering Rx Program Boasts Nearly $6B in Annual Profits
- Ahead of Senate Drug Pricing Hearing, Report Finds PhRMA CEOs Rewarded Selves & Investors While Hiking Patients’ Costs
- Eli Lilly Posts Huge Earnings as Big Pharma Fights Biden Administration on Lowering Prescription Drug Costs
- MEMO: Will PhRMA-Member CEOs Defend Price-Gouging & Donations to Election Deniers?
- Bristol Myers Squibb Annual Profits Soar After Price-Gouging U.S. Patients, Suing to Stop Medicare From Negotiating Lower Prices